VEGFA and age-related macular degeneration: Despite the overwhelming success of anti-VEGF intravitreal injections (IVI) in treating active CNV due to exudative AMD [194,195,196], there is still a subset of incomplete respondents (~15%) who have persistent sub-retinal fluid (with or without intra-retinal fluid) despite chronic continued treatment [197,198,199].